Profile of Dr María Berdasco
Dr. Berdasco is a molecular biologist with over 15 years of experience in the field of Clinical Epigenetics, firstly as principal researcher at the CNIO (Madrid) and IDIBELL (Barcelona) and recently as Head of the Epigenetic Therapies (EPITARGET) Research Group at Josep Carreras Leukaemia Research Institute. She has participated in international research consortia of European projects, covering funding schemes from the Cooperation Scheme in H2020 (ITN, RISE, COST) as well as she is principal investigator of various other privately funded endeavors and National Programs. To improve the group’s research lines in translational research some actions are promoted, including clinical-basic interactions, technological transfer, or agreements with private companies. An aspect of interest for the translational value of the research is her education and professional activities in Bioethics and management of human samples for biomedical research (MsC in Bioethics and Law-UNESCO). In 2019, she has been designated by the Spanish Ministry of Science and Technology as member of the Advisory Committee for Human Tissue and Cell donation and use, a management structure from the Sub-directorate general for Research on Cellular Therapy at the Instituto de Salud Carlos III.